Read the docs
TI-2021-11731 Aliases CVE-2021-31651GHSA-8cmf-fv34-9286

Cross Site Scripting (XSS) vulnerability in neofarg-cms 0.2.3 allows remoate attacker to…

Priority MEDIUM 55CWE-79Published · Updated

Key facts

Attack vector
Network
Privileges required
High
User interaction
Required
Attack complexity
Low
Impact type
Cross-site scripting
Confidentiality · integrity · availability
Low · Low · None
Fix status
No fix listed

Attack profile from CVSS 3.1 · NVD. Fix status from CNA. Impact type from CWE-79.

Summary

Cross Site Scripting (XSS) vulnerability in neofarg-cms 0.2.3 allows remoate attacker to run arbitrary code via the copyright field in copyright settings.

Why it matters now

Exploitation Proof of concept CISA SSVC · not in CISA KEV
EPSS 0.00341 27th percentileScored 2026-11-07
Fix No fix listed No fixed version in the sources yet

SSVC decision points

CISA ADP · SSVC 2.0.3

Exploitation
Poc
Automatable
No
Technical impact
Partial

The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.

Affected products

VendorProductAffected versionsFixed inStatusSource
——all versions—No fix listedCNA
  • — Vendor— Affected all versions Fixed in — No fix listed CNA

CPE configurations NVD · 1

CPEVersionsRoleVendor
cpe:2.3:a:neofr:neofrag:0.2.3:*:*:*:*:*:*:*0.2.3VulnerableNeofr
  • cpe:2.3:a:neofr:neofrag:0.2.3:*:*:*:*:*:*:* Versions 0.2.3 Vulnerable ·Neofr

Remediation

No fixed version listed by the sources yet.

Timeline

  1. 2026-10-02 Threatist record created from CVE-2021-31651
  2. 2026-10-03 Alias added: GHSA-8cmf-fv34-9286

References

Advisory 1

Sources

This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences